Patients' satisfaction with heroin-assisted treatment: a qualitative study

• Published in: Harm reduction journal 2023-06, Vol.20 (1), p.73-73, Article 73
• Main Authors: Ellefsen, Rune, Wüsthoff, Linda Elise Couëssurel, Arnevik, Espen Ajo
• Format: Article
• Language: English
• Subjects: Care and treatment; Clinical outcomes; Diacetylmorphine; Dosage and administration; Drug abuse; Drug addiction; Drug use; Empirical analysis; Environmental factors; Evaluation; Harm reduction; Health services; Heroin; Heroin - therapeutic use; Heroin-assisted treatment; Humans; Narcotics; Opioid use disorder; Opioid-Related Disorders - therapy; Opioids; Patient Satisfaction; Patients; Qualitative Research; Self Report; Socio-environmental factors; Substance abuse
• ISSN: 1477-7517; 1477-7517
• DOI: 10.1186/s12954-023-00808-8

Heroin-assisted treatment (HAT) involves supervised dispensing of medical heroin (diacetylmorphine) for people with opioid use disorder. Clinical evidence has demonstrated the effectiveness of HAT, but little is known about the self-reported satisfaction among the patients who receive this treatment. This study presents the first empirical findings about the patients' experiences of, and satisfaction with, HAT in the Norwegian context. Qualitative in-depth interviews with 26 patients in HAT were carried out one to two months after their enrollment. Analysis sought to identify the main benefits and challenges that the research participants experienced with this treatment. An inductive thematic analysis was conducted to identify the main areas of benefits and challenges. The benefits were weighed against the challenges in order to assess the participants' overall level of treatment satisfaction. Analysis identified three different areas of experienced benefits and three areas of challenges of being in this treatment. It outlines how the participants' everyday lives are impacted by being in the treatment and how this, respectively, results from the treatment's medical, relational, or configurational dimensions. We found an overall high level of treatment satisfaction among the participants. The identification of experienced challenges reveals factors that reduce satisfaction and thus may hinder treatment retention and positive treatment outcomes. The study demonstrates a novel approach to qualitatively investigate patients' treatment satisfaction across different treatment dimensions. The findings have implications for clinical practice by pointing out key factors that inhibit and facilitate patients' satisfaction with HAT. The identified importance of the socio-environmental factors and relational aspect of the treatment has further implications for the provision of opioid agonist treatment in general.